UBE2NL Antibodies

Santa Cruz Biotechnology delivers a wide array of UBE2NL monoclonal antibodies for research focused on understanding UBE2NL's role in cellular processes. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). UBE2NL, also known as Ubiquitin-conjugating enzyme E2 N-terminal-like, is a key component in the ubiquitin-proteasome system, essential for protein degradation and regulation of various cellular functions. UBE2NL participates in the modification of target proteins through ubiquitination, influencing processes such as cell cycle regulation, DNA repair, and signal transduction. Research has shown that UBE2NL activity has significant implications for understanding diseases, including cancer and neurodegenerative disorders. Investigating UBE2NL expression patterns and interactions provides valuable insights into cellular homeostasis and disease mechanisms. Advanced detection methods using specific molecular markers help reveal UBE2NL's distribution and activity in different cellular compartments. Researchers can utilize conjugated formats with horseradish peroxidase (HRP), phycoerythrin (PE), or fluorescein isothiocyanate (FITC) for enhanced visualization and quantification. Santa Cruz Biotechnology monoclonal antibodies for UBE2NL research contribute to advancing scientific understanding of cellular regulation and disease pathways.